This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Newsbyte: New Features In SAP® Travel OnDemand Solution Boost Mobility, Compliance And Global Efficiency

Stocks in this article: SAP

HANOVER, Germany, March 5, 2013 /PRNewswire/ --  SAP AG (NYSE: SAP) today announced significant updates to the SAP® Travel OnDemand solution, including broader country coverage, support for the Physician Payment Sunshine Act and new analytic, mobile and integration capabilities. SAP Travel OnDemand is a cloud-based, end-to-end, one-stop solution designed for seamless travel and expense management. The announcement was made at CeBIT 2013, being held March 5-9 in Hanover, Germany.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

"SAP Travel OnDemand helps reduce our travel expenses and makes booking and expense reporting and reimbursement so much easier," said Corby Brendle, practice director, UST Global. "We've seen a tangible business ROI since our implementation of SAP Travel OnDemand and the integration with our other business software has created a seamless end-user experience."

Built for the mobile business traveler, the latest updates to SAP Travel OnDemand aim to cut travel costs and complexity while maintaining compliance. New features include:

  • Broader country coverage: SAP Travel OnDemand now offers additional country versions supporting specific regulations for both local tax and local legal requirements for Belgium, Ireland and New Zealand, in addition to the 16 countries already supported out-of-the-box. With this update and the available international template, the solution is ready to be used in more than 100 countries, furthering SAP's commitment to meet customers' needs worldwide.
  • Support for the new Physician Payment Sunshine Act: A new federal act for medical devices and pharmaceutical companies requires companies to account for the benefits provided to physicians in the course of regular sales processes. This means travel, gifts, meals and other costs above US$10 must be reported. With SAP Travel OnDemand, pharmaceutical representatives can account for benefits provided in the normal course of business between the pharmaceutical sales rep and the physicians with whom they work.
  • Customized analytics: Addressing the unique needs of each employee, SAP Travel OnDemand offers role-based analytics across various users, including business travelers, managers, auditors and CFOs. Role-based user analytics significantly improve travel and expense management by providing the flexibility to customize decisions to fit the requirements of a specific user.
  • Android mobile version: The new Android app for SAP Travel OnDemand creates greater employee choice in devices, supporting business travelers to help manage their travel and expenses anytime, anywhere. Business travelers can now capture expenses and receipts at the point of purchase reports at any time.
  • Integration with the SAP® ERP application and SAP® Financials OnDemand solution: Intercompany cost assignment can now be integrated with the SAP® ERP Financials solution, accelerating the expense reimbursement process. Additionally, integration with SAP Financials OnDemand completes the "loosely coupled suite" strategy in the SAP Cloud.

To learn more, visit the SAP Travel OnDemand demo center. For more information, including additional news from SAP at CeBIT, visit the SAP Newsroom. Follow SAP on Twitter at @sapnews.

Media Contacts: Andrea Meyer, +1 (415) 370-7329, andrea.meyer01@sap.com, PST Torrey Fazen, Burson-Marsteller, +1 (617) 912-5401,  torrey.fazen@bm.com, EST

SOURCE SAP AG

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.16 -0.44 -0.00%
S&P 500 2,053.35 +1.53 0.07%
NASDAQ 4,761.6240 +3.7450 0.08%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs